China, People's Republic of INTRODUCTION AND OBJECTIVES: Heterochromatin protein 1 gamma (HP1?) is a non-histone heterochromatic protein, which plays an important role in maintaining the stability of chromatin and embryonic development. Recently, HP1? has been implied to be involved in the development and progression of cancer. Here, we investgated the association of HP1? expression with oncologic outcome of patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
INTRODUCTION AND OBJECTIVES: Significant disparities in survival, incidence and possibly response to current therapies exist between black and white patients with renal cell carcinoma (RCC). Recent genomic evidence to account for these disparities has been reported for clear cell RCC. However, racial disparities at the genomic level for papillary RCC (pRCC) which is a genetically distinct and less responsive histologic subtype of RCC have not been reported. Using The Cancer Genome Atlas (TCGA) data, the present study assessed differences in gene-level expression and pathway activity between black and white patients with pRCC.
METHODS: The TCGA dataset was used to identify 235 (54 black, 181 white) of 290 patients with an initial diagnosis of pRCC from 2001-2013. Black and white patients were propensity matched on age, gender and pathologic TNM stage. Supervised whole genome expression analysis using the SAMSeq package in R was conducted to identify genes differentially expressed genes (FDR<0.05). Gene Set Enrichment Analysis (GSEA) to evaluate differential activity of pathways and gene sets in white and black patient groups was also conducted. RESULTS: There were 167 genes and 47 genes identified as overexpressed in black and white patients, respectively (FDR<0.05). Gene Set Enrichment Analysis identified 111 gene sets enriched (p<0.05) in black patients, with differences in PI3K/AKT/mTOR signaling (p<.001) and immune system pathways being the most prevalent including T cell signal transduction (p<0.001), Interferon a/ß signaling (p¼.004), Interferon gamma response (p¼.018), B cell antigen receptor (p¼.018), IL-2 signaling (p¼.015) and MHC class II antigen presentation (p¼.012). PTPN20B and CRYBB2 associated with the PAK and WNT pathways were overexpressed in Black patients, respectively.
CONCLUSIONS: Distinct tumor biology between black and white patients was identified with differential activity of immune related pathways and signaling of the PI3K/AKT/mTOR pathway. While our data requires validation, these findings suggests that race may have implications for distinct immune responses to cancer and that the use of immunotherapies, VEGFR, mTOR, MEK and PI3K inhibitors to target these pathways may improve survival in black patients with advanced pRCC. Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e871
Source RESULTS: According to the ROC curve, the cutoff value for overall death was 1.6 (p¼0.002). The cancer-specific survival (CSS) and overall survival (OS) were significantly shorter for patients with a high De Ritis ratio (>1.6). Results of multivariable analysis identified an increased De Ritis ratio (>1.6) as independently related to worse CSS (hazard ratio [HR] 2.49, 95% confidence interval [CI] 1.70-3.64; p¼0.001) and OS (HR 1.84, 95% CI 1.34-2.52; p¼0.001).
CONCLUSIONS: Our results suggest that the De Ritis ratio can be a significant predictor of oncological outcomes in patients with upper urinary tract urothelial carcinoma after surgery. Recent studies have argued that the actual metastatic rate of eAML is very low. This retrospective study aims to analyze the aggressive behavior rate and describe the vast clinicopathalogical variety of eAML.
Source of
METHODS: In Chang Gung Memorial Hospital, Taiwan, a total of 887 patients were diagnosed with AML from 2001 to 2016 according to the healthcare information system archive, including 21 cases of renal eAML. All of the cases were diagnosed according to tissue proof and immunohistochemical studies. The images, pathology and medical records of these 21 eAML cases were reviewed and summarized.
RESULTS: In these 21 eAML cases, the average age was 43.1 (ranges from 18 to 64), including 6 males and 15 females. All 21 cases are not associated with tuberous sclerosis complex. The longest diameter of the tumors ranges from 1.3 to 20 centimeters (average 9.8 cm). Three of these cases had multiple tumors (single eAML and single AML coexist on the left kidney, clear cell renal cell carcinoma on the right and single eAML on the left, multiple AML on e872 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 
